Products
| Product Name | CAS No. | Specification | Application | Registration |
| Lopinavir | 192725-17-0 | 98+% | HIV inhibitor, anti-COVID | |
| RU 58841 | 154992-24-2 | 98+% | Anti-androgen, hair regrowth | |
| Limaprost | 74397-12-9 | 98+% | Vasodilator, anti-aggregation | |
| Arecoline Hydrobromide | 300-08-3 | 98+% | An AChR agonist for inflammation and cancer. | |
| D-erythro-Sphingosine | 123-78-4 | 98+% | A PKC inhibitor and anti-cancer agent in research. | |
| Auraptene | 495-02-3 | 98+% | Anti-inflammatory, anti-tumor properties in research. | |
| N-Acetyl-D-glucosamine | 7512-17-6 | 98+% | A key component in chitin and has applications in immunomodulation and osteoarthritis therapy. | |
| Triptolide | 38748-32-2 | 98+% | NF-κB activation inhibitor | |
| Celastrol | 34157-83-0 | 98+% | A proteasome inhibitor, has anti-cancer and anti-inflammatory properties | |
| Dihexa | 1401708-83-5 | 98+% | Dihexa, an angiotensin IV analog, is a cognitive enhancer. | |
| 5-Hydroxymethylfurfural (HMF) | 67-47-0 | 98+% | 5-HMF inhibits yeast, key in biofuels and polymers research. | |
| 24, 25-Dihydroxy VD3 | 40013-87-4 | 98+% | A vitamin D3 metabolite with potential in calcium regulation and bone health research | |
| Osimertinib mesylate | 1421373-66-1 | 98+% | Anti-cancer | EGFR | |
| Osimertinib | 1421373-65-0 | 98+% | Anti-cancer research | EGFR | |
| Retatrutide | 2381089-83-2 | 98+% | Research on Obesity | GLP Receptor |
Products
Custom Synthesis-High Value-Added Advanced Pharmaceutical Intermediates
E-Mail: sales (at)Chemleader.com.cn
E-Mail: sales (at)Chemleader.com.cn